CLARIVATE PLC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CLVT in the last 30 days.
See all $CLVT insider activity →Clarivate Plc (NYSE: CLVT) announced a cash tender offer to purchase up to $75M of its 3.875% Senior Secured Notes due 2028. The offer, managed by Citigroup, expires on September 23, 2026, with a settlement date of September 25, 2026. The total consideration is based on a fixed spread and reference yield, with accrued interest also payable.
CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary,
Cornick Kenneth L. purchased 900,000 indirectly-held shares of CLARIVATE PLC (CLVT) at an average of $1.86 ($1.85–$1.86, $1.67M total) across 2 trades over 2026-08-06 to 2026-08-07.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning CLVT (CLARIVATE PLC). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent CLVT coverage spans corporate actions, insider activity and financial news.
The tender offer may provide liquidity to note holders and could affect Clarivate's credit profile and stock perception.
The tender offer may pressure the price of Clarivate's debt and could affect equity sentiment as investors assess liquidity and capital structure.
This is an insider open-market purchase, which can be read as modest bullish signaling, but it is not a fundamental catalyst like earnings or guidance.
Segment divestiture can refocus the portfolio and affect earnings mix, leverage, and capital allocation.
This is a product and platform expansion announcement that could support incremental demand for Clarivate’s life-sciences workflow offerings, but it lacks financial guidance or quantified traction.
AlphAI scores every news story that mentions CLVT with an AI model for sentiment and relevance, and aggregates insider trades from CLARIVATE PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Clarivate Plc (NYSE: CLVT) announced a cash tender offer to purchase up to $75M of its 3.875% Senior Secured Notes due 2028. The offer, managed by Citigroup, expires on September 23, 2026, with a settlement date of September 25, 2026. The total consideration is based on a fixed spread and reference yield, with accrued interest also payable.
2 min readCLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary,
1 min readCornick Kenneth L. purchased 900,000 indirectly-held shares of CLARIVATE PLC (CLVT) at an average of $1.86 ($1.85–$1.86, $1.67M total) across 2 trades over 2026-08-06 to 2026-08-07.
1 min readPR Newswire compiled 13 July press releases, including Lilly’s Phase 3 retatrutide results, Kroger’s agreement to acquire Giant Eagle, Clarivate’s sale of its Life Sciences and Healthcare segment for $600 million, BOXABL’s business combination valuing it at $3.5 billion, and Garmin’s LiveScope 2 sonar launch. It also lists other product and corporate updates.
7 min readClarivate Plc (NYSE:CLVT) said it expanded agentic AI capabilities across its Cortellis life sciences portfolio. The company claims the updates embed AI into existing workflows to speed drug discovery decisions, improve safety assessment via multi-agent intelligence, and accelerate competitive and portfolio analysis. Clarivate said the goal is reducing manual effort and improving decision making across the R&D lifecycle.
3 min readSnyder Andrew Miles sold 2,489,618 indirectly-held shares of CLARIVATE PLC (CLVT) at $1.94 ($4.83M total) across 3 trades on 2026-08-03.
2 min readSimply Wall St reports Clarivate Plc (CLVT) appointed Michael Easton as CFO and Executive Vice President effective Aug. 8, 2026, after Jonathan Collins’ departure. Easton previously served as Chief Accounting Officer overseeing controllership, reporting, treasury and FP&A. The article links the change to Clarivate’s capital discipline and cites forecasts of $1.9B revenue and $142.7M earnings by 2029.
5 min readClarivate Plc (Q2 2026) discussed its Value Creation Plan to shift from transactional to recurring subscription revenue. It plans to divest the Life Sciences & Healthcare segment by year-end 2026, targeting about 92% recurring revenue pro forma. Management cited a $269m non-cash impairment, $70m one-time costs, and expects low-end FCF due to transaction and restructuring costs.
6 min readClarivate Plc reported a tranche update on its equity buyback plan announced Dec. 16, 2024. From Apr. 1, 2026 to Jun. 30, 2026 it repurchased 0 shares for $0 million. Cumulatively it has bought back 63,042,889 shares, or 9.41%, for $242.63 million.
2 min readCLARIVATE PLC (CLVT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Clarivate Appoints Michael Easton as Chief Financial Officer Experienced Clarivate leader brings more than 25 Years of financial and operational expertise LONDON, July 29, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative
2 min read
